22552 Federal Register / Vol. 80, No. 77 / Wednesday, April 22, 2015 / Notices 

Register pursuant to Section 6(b) of the 

Act on February 6, 2015 (80 FR 6768). 

Patricia A. Brink, 

Director of Civil Enforcement, Antitrust 

Division. 

[FR Doc. 2015–09317 Filed 4–21–15; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Unither Manufacturing, 

LLC 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic class, and applicants 

therefore, may file written comments on 

or objections to the issuance of the 

proposed registration in accordance 

with 21 CFR 1301.34(a) on or before 

May 22, 2015. Such persons may also 

file a written request for a hearing on 

the application pursuant to 21 CFR 

1301.43 on or before May 22, 2015. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODXL, 8701 

Morrissette Drive, Springfield, Virginia 

22152. Request for hearings should be 

sent to: Drug Enforcement 

Administration, Attention: Hearing 

Clerk/LJ, 8701 Morrissette Drive, 

Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Deputy Assistant 

Administrator of the DEA Office of 

Diversion Control (‘‘Deputy Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on July 10, 

2014, Unither Manufacturing LLC, 331 

Clay Road, Rochester, New York 14623 

applied to be registered as an importer 

of methylphenidate (1724), a basic class 

of controlled substance listed in 

schedule II. 

The company plans to import the 

listed substance as a raw material for 

updated testing purposes for EU 

customer requirements. 

The company plans to import the 

listed controlled substance in finished 

dosage form (FDF) from foreign sources 

for analytical testing and clinical trials 

in which the foreign FDF will be 

compared to the company’s own 

domestically-manufactured FDF. This 

analysis is required to allow the 

company to export domesticallymanufactured FDF to foreign markets. 

Dated: April 14, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–09337 Filed 4–21–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Sigma-Aldrich 

International GMBH, Sigma Aldrich 

Co., LLC 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration in 

accordance with 21 CFR 1301.34(a) on 

or before May 22, 2015. Such persons 

may also file a written request for a 

hearing on the application pursuant to 

21 CFR 1301.43 on or before May 22, 

2015. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODXL, 8701 

Morrissette Drive, Springfield, Virginia 

22152. Comments and requests for 

hearings on applications to import 

narcotic raw material are not 

appropriate. 72 FR 3417 (January 25, 

2007). 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importer, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Deputy Assistant 

Administrator of the DEA Office of 

Diversion Control (‘‘Deputy Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on 

February 5, 2015, Sigma-Aldrich 

International GMBH, Sigma Aldrich Co. 

LLC, 3500 Dekalb Street, St. Louis, 

Missouri 63118 applied to be registered 

as an importer of the following basic 

classes of controlled substances: 

Controlled substance Schedule 

Cathinone (1235) .......................... I 

Methcathinone (1237) .................. I 

Mephedrone (4-Methyl-Nmethylcathinone) (1248).I 

N-Ethylamphetamine (1475) ........ I 

Aminorex (1585) ........................... I 

Gamma Hydroxybutyric Acid 

(2010).

I 

Methaqualone (2565) ................... I 

Alpha-ethyltryptamine (7249) ....... I 

Ibogaine (7260) ............................ I 

Lysergic acid diethylamide (7315) I 

Marihuana (7360) ......................... I 

Tetrahydrocannabinols (7370) ..... I 

Mescaline (7381) .......................... I 

4-Bromo-2,5- 

dimethoxyamphetamine (7391).

I 

4-Bromo-2,5- 

dimethoxyphenethylamine 

(7392).

I 

4-Methyl-2,5- 

dimethoxyamphetamine (7395).

I 

2,5-Dimethoxyamphetamine 

(7396).

I 

3,4-Methylenedioxyamphetamine 

(7400).

I 

N-Hydroxy-3,4- 

methylenedioxyamphetamine 

(7402).

I 

3,4-Methylenedioxy-Nethylamphetamine (7404).I 

3,4- 

Methylenedioxymethamphetamine (7405).

I 

4-Methoxyamphetamine (7411) ... I 

Bufotenine (7433) ......................... I 

Diethyltryptamine (7434) .............. I 

Dimethyltryptamine (7435) ........... I 

Psilocybin (7437) .......................... I 

Psilocyn (7438) ............................. I 

1-[1-(2- 

Thienyl)cyclohexyl]piperidine 

(7470).

I 

N-Benzylpiperazine (7493) ........... I 

MDPV (3,4- 

Methylenedioxypyrovalerone) 

(7535).

I 

Heroin (9200) ............................... I 

Normorphine (9313) ..................... I 

Etonitazene (9624) ....................... I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Methylphenidate (1724) ................ II 

Amobarbital (2125) ....................... II 

Pentobarbital (2270) ..................... II 

Secobarbital (2315) ...................... II 

Glutethimide (2550) ...................... II 


asabaliauskas on DSK5VPTVN1PROD with NOTICES